Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.961 USD | +1.12% | -2.48% | -33.94% |
05-07 | Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.94% | 167M | |
+9.86% | 115B | |
+11.79% | 106B | |
-2.59% | 21.96B | |
-13.42% | 21.87B | |
-5.29% | 19.21B | |
-2.97% | 18.08B | |
-38.57% | 17.71B | |
+6.29% | 14.32B | |
+33.82% | 12.42B |
- Stock Market
- Equities
- RIGL Stock
- News Rigel Pharmaceuticals, Inc.
- Peter S. Ringrose Announces Not to Stand for Re-Election to Board of Rigel Pharmaceuticals, Inc